Patents by Inventor Dejian Ren

Dejian Ren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170164591
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 15, 2017
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Publication number: 20170107269
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: August 19, 2016
    Publication date: April 20, 2017
    Inventors: David CLAPHAM, Dejian REN
  • Patent number: 9618521
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: April 11, 2017
    Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
  • Publication number: 20150219629
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: September 2, 2014
    Publication date: August 6, 2015
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David CLAPHAM, Dejian REN
  • Publication number: 20140363813
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: April 10, 2014
    Publication date: December 11, 2014
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Patent number: 8852860
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: October 7, 2014
    Assignee: Children's Medical Center Corporation
    Inventors: David Clapham, Dejian Ren
  • Patent number: 8729248
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: May 20, 2014
    Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
  • Publication number: 20130102495
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: May 30, 2012
    Publication date: April 25, 2013
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David E. CLAPHAM, Dejian REN
  • Patent number: 8211666
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Grant
    Filed: October 30, 2003
    Date of Patent: July 3, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: David E. Clapham, Dejian Ren
  • Patent number: 7790845
    Abstract: The present invention relates to a functionally expressed bacterial voltage-sensitive ion-selective channel. The novel channel can be used in conjunction with mammalian ion channel pore-containing regions in assays for screening for compounds that modulate activity of the channel. One bacterial ion channel of the present invention, called NaChBac, is derived from Bacillus halodurans (GenBank#BAB05220 (8)).
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: September 7, 2010
    Assignee: Children's Medical Center Corporation
    Inventors: David Clapham, Dejian Ren
  • Publication number: 20090104604
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: January 29, 2008
    Publication date: April 23, 2009
    Applicants: CHILDREN'S MEDICAL CENTER CORPORATION, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Publication number: 20050142566
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: April 21, 2004
    Publication date: June 30, 2005
    Applicants: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David Garbers, Timothy Quill
  • Publication number: 20050101767
    Abstract: The present invention relates to a functionally expressed bacterial voltage-sensitive ion-selective channel. The novel channel can be used in conjunction with mammalian ion channel pore-containing regions in assays for screening for compounds that modulate activity of the channel. One bacterial ion channel of the present invention, called NaChBac, is derived from Bacillus halodurans (GenBank#BAB05220 (8)).
    Type: Application
    Filed: November 5, 2002
    Publication date: May 12, 2005
    Inventors: David Clapham, Dejian Ren
  • Publication number: 20040157292
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: October 30, 2003
    Publication date: August 12, 2004
    Applicant: Children's Medical Center
    Inventors: David E. Clapham, Dejian Ren
  • Patent number: 6207410
    Abstract: The present invention provides for the isolation and characterization of an invertebrate calcium channel subunit gene.
    Type: Grant
    Filed: July 16, 1997
    Date of Patent: March 27, 2001
    Assignee: The Research Foundation of State University of New York
    Inventors: Linda M. Hall, Dejian Ren, Wei Zheng, Manuel Marcel Paul Dubald
  • Patent number: 6027912
    Abstract: The present invention provides for the isolation and characterization of a calcium channel al subunit gene cloned from Drosophila melanogaster, and designated "DmcalD".
    Type: Grant
    Filed: January 19, 1995
    Date of Patent: February 22, 2000
    Assignee: The Research Foundation of State University of New York
    Inventors: Linda M. Hall, Dejian Ren, Wei Zheng, Manuel Marcel Paul Dubald